Barrington Research Forecasts Strong Price Appreciation for Option Care Health (NASDAQ:OPCH) Stock

Option Care Health (NASDAQ:OPCH) had its price target boosted by Barrington Research from $32.00 to $33.00 in a research note issued to investors on Tuesday,Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Barrington Research’s target price indicates a potential upside of 14.74% from the stock’s previous close.

A number of other research analysts have also issued reports on the stock. Truist Financial reduced their target price on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a research note on Friday, November 1st. The Goldman Sachs Group downgraded Option Care Health from a “buy” rating to a “neutral” rating and reduced their price objective for the stock from $38.00 to $27.00 in a research report on Monday, November 4th. Bank of America raised Option Care Health from a “neutral” rating to a “buy” rating and increased their price objective for the stock from $26.00 to $33.00 in a report on Monday. Jefferies Financial Group downgraded Option Care Health from a “buy” rating to a “hold” rating and cut their target price for the company from $38.00 to $26.00 in a research note on Thursday, October 31st. Finally, JMP Securities reiterated a “market outperform” rating and set a $30.00 price target (down previously from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. Three investment analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $29.86.

Option Care Health Stock Performance

OPCH stock opened at $28.76 on Tuesday. Option Care Health has a 1 year low of $21.39 and a 1 year high of $34.63. The stock has a market capitalization of $4.89 billion, a price-to-earnings ratio of 24.17, a PEG ratio of 2.43 and a beta of 1.31. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The stock’s fifty day moving average is $23.33 and its two-hundred day moving average is $27.70.

Insider Activity

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of Option Care Health stock in a transaction dated Friday, November 8th. The stock was bought at an average price of $22.54 per share, for a total transaction of $969,220.00. Following the transaction, the director now owns 326,334 shares in the company, valued at approximately $7,355,568.36. This trade represents a 15.18 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.64% of the stock is owned by insiders.

Institutional Trading of Option Care Health

Hedge funds and other institutional investors have recently made changes to their positions in the business. FMR LLC grew its position in Option Care Health by 134.0% in the third quarter. FMR LLC now owns 7,516,448 shares of the company’s stock worth $235,265,000 after buying an additional 4,304,896 shares during the last quarter. Massachusetts Financial Services Co. MA acquired a new stake in shares of Option Care Health during the 2nd quarter valued at $68,003,000. Victory Capital Management Inc. boosted its stake in shares of Option Care Health by 4,432.8% during the 3rd quarter. Victory Capital Management Inc. now owns 1,621,593 shares of the company’s stock worth $50,756,000 after acquiring an additional 1,585,818 shares in the last quarter. Magnetar Financial LLC grew its holdings in shares of Option Care Health by 124.8% in the 2nd quarter. Magnetar Financial LLC now owns 2,481,935 shares of the company’s stock worth $68,750,000 after acquiring an additional 1,377,929 shares during the last quarter. Finally, Wellington Management Group LLP grew its holdings in shares of Option Care Health by 15.5% in the 3rd quarter. Wellington Management Group LLP now owns 9,924,915 shares of the company’s stock worth $310,650,000 after acquiring an additional 1,328,326 shares during the last quarter. 98.05% of the stock is currently owned by institutional investors.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.